Acquisition by Arbel Irit of 30666 shares of Brainstorm Cell subject to Rule 16b-3

BCLI Stock  USD 1.89  0.10  5.03%   
Under 61% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
Filed transaction by Brainstorm Cell Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Brainstorm insider trading alert for acquisition of common stock by Arbel Irit, Director, on 1st of January 2025. This event was filed by Brainstorm Cell Therapeutics with SEC on 2025-01-01. Statement of changes in beneficial ownership - SEC Form 4

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

Brainstorm Cell is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

XFORX4 Pharmaceuticals   10.87   
0%
100.0%
GBIOGeneration Bio   6.74   
0%
62.0%
CRVSCorvus Pharmaceuticals   5.92   
0%
54.0%
HCWBHCW Biologics   2.78   
0%
25.0%
CUECue Biopharma   2.34   
0%
21.0%
PLXProtalix Biotherapeutics   2.30   
0%
21.0%
BCABBioatla   2.08   
0%
19.0%
CCCCC4 Therapeutics   2.07   
0%
19.0%
PASGPassage Bio   1.69   
0%
15.0%
ANTXAN2 Therapeutics   1.60   
0%
14.0%
GRIGRI Bio   1.41   
0%
12.0%
ALDXAldeyra   1.26   
0%
11.0%
DAWNDay One   1.13   
0%
10.0%
CNTBConnect Biopharma   0.96   
0%
8.0%
TRVITrevi Therapeutics   0.53   
4.0%
0%
HOWLWerewolf Therapeutics   0.75   
6.0%
0%
MREOMereo BioPharma   1.38   
12.0%
0%
INZYInozyme Pharma   1.45   
13.0%
0%
TERNTerns Pharmaceuticals   1.56   
14.0%
0%
EWTXEdgewise Therapeutics   1.72   
15.0%
0%
CELCCelcuity LLC   2.84   
26.0%
0%
CKPTCheckpoint Therapeutics   4.50   
41.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account